Age-related macular degeneration market expected to grow to $22.8bn in 2031
The AMD market is projected to grow strongly over the next nine years, but there are potential barriers to this…
By
Markets
Latest in
Markets
Return of the SPAC? Blank check companies not extinct as European bio shell launches
A special purpose acquisition company (SPAC) focused on CDMOs has launched even as fundraising shell companies lose traction.
By
Why did the cannabis industry blossom during the pandemic?
Global legal cannabis sales in 2020 were up by 45% on 2019, with several leading companies reporting triple-digit revenue growth.
By
Kalbe and Amarox partner to market Covid-19 drug
Movfor is the first branded Molnupiravir variant that received EUA from BPOM RI in Indonesia.
Glaucoma market set to continue steady global growth
It is unlikely that a new treatment class will overtake prostaglandin analogues as a first-line glaucoma treatment until 2030.
By
Endometriosis: how the market has developed and where it needs to be
There is a need for greater endometriosis awareness across the market, with the development of non-invasive diagnosis and more efficient…
By
UK life sciences trade group calls for oral Covid-19 antiviral investment
The UK government must invest in Covid-19 antiviral treatments like it did with vaccines, said the chair of the UK…
By
Integra Therapeutics Q&A: building next-generation gene editing tools
Integra Therapeutics’ CEO discusses how the company’s gene writing tool could improve advanced therapies for patients.
By